Please assess the completion status of the following clinical trial:

Trial Title: Gel-200 Versus Placebo in Osteoarthritis of the Knee

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects with a diagnosis of painful, symptomatic tibio-femoral osteoarthritis of the knee (Grade 1-3 on Kellgren - Lawrence (K-L) score).~Exclusion Criteria:~* Subjects with Grade 4 on K-L score~* Subjects with inflammatory diseases of the knee other than osteoarthritis such as rheumatoid arthritis~* Serious systemic diseases~* Female subjects who are pregnant or lactating

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Gel-200 (Type: EXPERIMENTAL): None
- PBS (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).